Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Ixazomib is a targeted, reversible proteasome inhibitor that has been approved f···【more】
Release date：2026-01-07Recommended：30
Ixazomib is part of an all-oral treatment regimen. When used in combination with···【more】
Release date：2026-01-07Recommended：35
On September 9, 2015, Cambridge, Massachusetts, USA, and Osaka, Japan, announced···【more】
Release date：2026-01-07Recommended：27
The U.S. Food and Drug Administration (FDA) approved ixazomib today for use in c···【more】
Release date：2026-01-07Recommended：30
Ivosidenib is available only with a doctor's prescription.Important Precauti···【more】
Release date：2026-01-07Recommended：33
KRAS G12C mutation in non-small cell lung cancer and colorectal cancer【more】
Release date：2026-01-06Recommended：0
Larotrectinib is indicated for the treatment of adult and pediatric patients wit···【more】
Release date：2026-01-06Recommended：0
Non-small cell lung cancer【more】
Release date：2026-01-06Recommended：10
Gilteritinib is suitable for Leukemia.【more】
Release date：2026-01-06Recommended：0
Capmatinib is indicated for the treatment of adult patients with metastatic non-···【more】
Release date：2026-01-06Recommended：28
Treatment of refractory relapsed multiple myeloma and certain types of diffuse l···【more】
Release date：2026-01-06Recommended：4
It is indicated for patients with susceptible isocitrate dehydrogenase-1 (IDH1) ···【more】
Release date：2026-01-06Recommended：15
